Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway

doi:10.1038/onc.2017.156

CNU IR > Pharmacy and Science > Dept. of Pharmacy > Periodical Articles > Item 310902800/31740

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/31740

Title:	Protein disulfide isomerase a4 acts as a novel regulator of cancer growth through the procaspase pathway
Authors:	Kuo, T-F Chen, T-Y Jiang, S-T Chen, K-W Chiang, Y-M Hsu, Y-J Liu, Y-J Chen, H-M Yokoyama, K. K. Tsai, K-C Yeh, H-H Chen, Y-R Yang, M-T Yang, C-Y Yang, W-C
Contributors:	Acad Sinica, Agr Biotechnol Res Ctr Natl Taiwan Univ, Inst Biotechnol Natl Appl Res Labs, Natl Lab Anim Ctr Kaohsiung Med Univ, Grad Inst Med Natl Res Inst Chinese Med, Minist Hlth & Welf Taipei Med Univ, PhD Program Biotechnol Med Chia Nan Univ Pharm & Sci, Drug Discovery & Dev Ctr Natl Chung Hsing Univ, Grad Inst Biotechnol Acad Sinica, Taiwan Int Grad Program, Mol & Biol Agr Sci Natl Chung Hsing Univ Natl Chung Hsing Univ, Dept Life Sci Natl Yang Ming Univ, Inst Pharmacol Natl Taiwan Ocean Univ, Dept Aquaculture
Keywords:	Endoplasmic-Reticulum Stress Induced Cell-Death Oxidoreductase Erp57 Induced Apoptosis Inhibition Identification Generation Expression Viability Discovery
Date:	2017-09-28
Issue Date:	2018-11-30 15:54:55 (UTC+8)
Publisher:	Nature Publishing Group
Abstract:	Protein disulfide isomerase a4 (PDIA4) is implicated in the growth and death of tumor cells; however, its molecular mechanism and therapeutic potential in cancer are unclear. Here, we found that PDIA4 expression was upregulated in a variety of tumor cell lines and human lung adenocarcinoma tissues. Knockdown and overexpression of PDIA4 in tumor cells showed that PDIA4 facilitated cell growth via the reduction of caspases 3 and 7 activity. Consistently, Lewis lung carcinoma cells overexpressing PDIA4 grew faster than did parental cells in tumor-bearing mice, as shown by a reduced survival rate, increased tumor size and metastasis, and decreased cell death and caspases 3 and 7 activity. PDIA4 knockdown resulted in opposite outcomes. Moreover, results obtained in mice with spontaneous hepatoma indicated that PDIA4 deficiency significantly reduced hepatic tumorigenesis and cyst formation and increased mouse survival, tumor death, and caspases 3 and 7 activity. Mechanistic studies illustrated that PDIA4 negatively regulated tumor cell death by inhibiting degradation and activation of procaspases 3 and 7 via their mutual interaction in a CGHC-dependent manner. Finally, we found that 1,2-dihydroxytrideca-5,7,9,11-tetrayne, a PDIA4 inhibitor, reduced tumor development via enhancement of caspase-mediated cell death in TSA tumor-bearing mice. These findings characterize PDIA4 as a negative regulator of cancer cell apoptosis and suggest that PDIA4 is a potential therapeutic target for cancer.
Relation:	Oncogene, v.36, n.39, pp.5484-5496
Appears in Collections:	[Dept. of Pharmacy] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	1104	View/Open

Loading...